FDA’s Opioid Guidance: Industry Celebrates Multi-Tiered Labeling Cake

Endo says label differentiation in the guidance is a positive step; Commissioner Hamburg tells Congress that if new opioid formulations “significantly” deter abuse, generic versions will have to as well.